Teladoc Health Q2 2024 Adj EPS $(0.28) Beats $(0.35) Estimate, Sales $642.444M Miss $649.650M Estimate
Portfolio Pulse from Benzinga Newsdesk
Teladoc Health (NYSE:TDOC) reported Q2 2024 adjusted EPS of $(0.28), beating the analyst estimate of $(0.35). However, sales of $642.444 million missed the $649.650 million estimate and decreased by 1.53% year-over-year.
July 31, 2024 | 9:20 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Teladoc Health's Q2 2024 adjusted EPS of $(0.28) beat estimates, but sales of $642.444 million missed expectations and decreased year-over-year. This mixed result may lead to short-term volatility in the stock price.
While the EPS beat is a positive sign, the sales miss and year-over-year decline in revenue may concern investors. This mixed result is likely to cause short-term volatility in Teladoc Health's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100